Loading…
First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction
Objective To evaluate marker distribution of free β‐human chorionic gonadotrophin (fβ‐hCG) and pregnancy‐associated plasma protein‐A (PAPP‐A) in singleton pregnancies conceived by assisted reproduction techniques (ART). Methods In vitro fertilization (IVF) (n = 203) and intracytoplasmic sperm inject...
Saved in:
Published in: | Prenatal diagnosis 2010-04, Vol.30 (4), p.372-377 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective
To evaluate marker distribution of free β‐human chorionic gonadotrophin (fβ‐hCG) and pregnancy‐associated plasma protein‐A (PAPP‐A) in singleton pregnancies conceived by assisted reproduction techniques (ART).
Methods
In vitro fertilization (IVF) (n = 203) and intracytoplasmic sperm injection (ICSI) (n = 192) cases from a database of 14 645 first‐trimester combined tests (overall study group) were selected and matched to 1164 controls for gestational age at sample date and maternal age.
Results
In the IVF group and ICSI group, lnPAPP‐A was lower (IVF 6.74 vs 7.08; P = 0.0001; ICSI 6.59 vs 7.07; P = 0.0001) compared with the matched controls. Lnfβ‐hCG was lower in the IVF group (3.75 vs 3.90; P = 0.005) but not significantly different in the ICSI group (3.87 vs 3.93; P = 0.27). The computed correction factors for PAPP‐A and fβ‐hCG were 1.42 and 1.17 for the IVF group and 1.56 and 1.05 for the ICSI group.
The false‐positive rate (FPR) in the IVF and ICSI group compared with the matched controls was higher (IVF 10.3% vs 8.6% and ICSI 10.9% vs 7.5%). In the overall age‐biased [maternal age significantly lower compared with all ART and control groups] study group the FPR was 6.8%.
Conclusion
The increase in FPR in the ART groups can be explained by decreased PAPP‐A values. Therefore, an adjustment in risk analysis for Down syndrome is suggested. Copyright © 2010 John Wiley & Sons, Ltd. |
---|---|
ISSN: | 0197-3851 1097-0223 |
DOI: | 10.1002/pd.2495 |